Clinical Trial Update: A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of a single intravenous dose of ASP2409 in patients with rheumatoid arthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP2409

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Rheumatoid Arthritis, Pharmacokinetics of ASP2409 | Phase 1 | Status: COMPLETED